中文名称  磷酸化细胞核因子/k基因结合核因子p100抗体规格 

英文名称  Anti-Phospho-NFKB2(Ser866+Ser870)

别    名 NFKB2(phospho S869/S870); NFKB2(phospho Ser869/Ser870); p-NFKB2(S869/S870); p-NFKB2(Ser869/Ser870); DNA binding factor KBF2; H2TF1; Lymphocyte translocation chromosome 10; Lyt10; Oncogene Lyt 10; DNA binding factor KBF2; DNA-binding factor KBF2; H2TF1; Lymphocyte translocation chromosome 10; Lymphocyte translocation chromosome 10 protein; Lyt 10; Lyt10; NFKB2; NFKB2_HUMAN; Nuclear factor NF kappa B p100 subunit; Nuclear factor NF kappa B p52 subunit; Nuclear factor NF-kappa-B p52 subunit; Nuclear factor of kappa light polypeptide gene enhancer in B cells 2; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2; Oncogene Lyt 10; Oncogene Lyt-10; p49/p100.

产品属性：

磷酸化细胞核因子/k基因结合核因子p100抗体规格 浓    度  1mg/1ml

规 格  0.1ml/100μg

抗体来源  Rabbit

克隆类型   polyclonal

交叉反应   Human, Mouse, Rat

产品类型   一抗 磷酸化抗体  

研究领域     免疫学 信号转导 细胞凋亡 转录调节因子 激酶和磷酸酶

蛋白分子量  predicted molecular weight: 50/100kDa 

性    状   Lyophilized or Liquid

免 疫 原  KLH conjugated Synthesised phosphopeptide derived from human NF-κB2 p100 around the phosphorylation site of Ser866/870

亚    型  IgG

纯化方法   affinity purified by Protein A

储 存 液   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

磷酸化细胞核因子/k基因结合核因子p100抗体规格 产品应用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蜡切片需做抗原修复） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存条件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

产品介绍 NFkB is formed through the association of multiple subunits, either as a homodimer or heterodimer. Subunits have been identified as p50 (NFkB1), p65 (RelA), c-Rel, RelB and p52 (NFkB2). The classic NFkB form exists as a p50-p65 heterodimer and predominates in many cell types. Many of the possible combinatorial forms of homo- and heterodimers have been identified and growing evidence indicates that different forms of NFkB have different functions in cells. Interestingly, both the p50 and p52 subunits are derived from the precursor proteins p105 and p100 respectively, that each contain multiple copies of the so called ankyrin repeat at their C termini. Nuclear translocation of NFkB is confirmed by the use of electrophorectic mobility shift assays or by immunoblotting with nuclear extracts. The subunit composition of NFkB is confirmed by the use of antibodies that "supershift" the DNA/protein complex.

Function : NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. In a non-canonical activation pathway, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. The NF-kappa-B heterodimeric RelB-p52 complex is a transcriptional activator. The NF-kappa-B p52-p52 homodimer is a transcriptional repressor. NFKB2 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p100 and generation of p52 by a cotranslational processing. The proteasome-mediated process ensures the production of both p52 and p100 and preserves their independent function. p52 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. p52 and p100 are respectively the minor and major form; the processing of p100 being relatively poor. Isoform p49 is a subunit of the NF-kappa-B protein complex, which stimulates the HIV enhancer in synergy with p65.Subunit : Component of the NF-kappa-B RelB-p52 complex. Homodimer; component of the NF-kappa-B p52-p52 complex. Component of the NF-kappa-B p65-p52 complex. Component of the NF-kappa-B p52-c-Rel complex. NFKB2/p52 interacts with NFKBIE. Component of a complex consisting of the NF-kappa-B p50-p50 homodimer and BCL3. Directly interacts with MEN1.Subcellular Location : Nucleus. Cytoplasm. Note=Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor (I-kappa-B).Post-translational modifications : While translation occurs, the particular unfolded structure after the GRR repeat promotes the generation of p52 making it an acceptable substrate for the proteasome. This process is known as cotranslational processing. The processed form is active and the unprocessed form acts as an inhibitor (I kappa B-like), being able to form cytosolic complexes with NF-kappa B, trapping it in the cytoplasm. Complete folding of the region downstream of the GRR repeat precludes processing.Subsequent to MAP3K14-dependent serine phosphorylation, p100 polyubiquitination occurs then triggering its proteasome-dependent processing.Constitutive processing is tightly suppressed by its C-terminal processing inhibitory domain, named PID, which contains the death domain.DISEASE : Note=A chromosomal aberration involving NFKB2 is found in a case of B-cell non Hodgkin lymphoma (B-NHL). Translocation t(10;14)(q24;q32) with IGHA1. The resulting oncogene is also called Lyt-10C alpha variant.Note=A chromosomal aberration involving NFKB2 is found in a cutaneous T-cell leukemia (C-TCL) cell line. This rearrangement produces the p80HT gene which encodes for a truncated 80 kDa protein (p80HT).Note=In B-cell leukemia (B-CLL) cell line, LB40 and EB308, can be found after heterogeneous chromosomal aberrations, such as internal deletions.Similarity : Contains 7 ANK repeats.Contains 1 death domain.Contains 1 RHD (Rel-like) domain.Database links : UniProtKB/Swiss-Prot: Q00653.4

实验流程：

全、新、优、品、好四大特点：

磷酸化细胞核因子/k基因结合核因子p100抗体规格 全：公司提供上万种产品，涵盖了生物试剂，elisa试剂盒，标准品，培养基，原装耗材，抗体、培养基、ATCC细胞等，基本上各种科研所需产品在我司都能找到。

新：产品更新速度较快，基本上每周都有新产品出现。

优：产品质量好，投诉比较少。

好：我公司具有优质的技术团队，产品一旦售出，实验过程中遇到困难可提供在线技术咨询。使您使用产品时没有任何的后顾之忧。

技术外包服务:

★磷酸化细胞核因子/k基因结合核因子p100抗体规格 分子生物学：质粒抽提、PCR、Q-PCR、RT-PCR、分子生物学：基因合成、引物合成、基因测序、载体构建等

★蛋白工程：原核、哺乳动物蛋白表达系统等

★病毒包装：腺病毒、慢病毒等

★抗体工程：磁珠分选、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★细胞工程：细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。

正在热销的相关产品：

ERK(Extracellular signal-regulated kinase) 原活化蛋白激酶抗原Multi-class antibodies规格： 0.5mg

精氨酸加压素受体2抗体 Anti-AVPR2 0.1ml

Rhesus antibody Rh Phospho-EGFR (Tyr1101) 磷酸化表皮生长因子受体抗体 规格 0.1ml

1640培养液 250ml 国产

ZNT8 英文名称： 锌转运体8蛋白抗体 0.2ml

DTNB 英文名称： 肌Dystrobrevin β蛋白抗体 0.2ml

精氨酸加压素受体2抗体 Anti-AVPR2 0.1ml

ER- Alpha(phospho-Tyr537)peptide 磷酸化雌激素受体α抗原Multi-class antibodies规格： 0.5mg

极光激酶B抗体 Anti-Aurora B 0.1ml

Rhesus antibody Rh phospho-EGFR (Thr693) 磷酸化表皮生长因子受体抗体 规格 0.1ml

D-MEM/F-12培养基(原装) 10×1L Gibco

ZNF532 英文名称： 锌指蛋白532抗体 0.2ml

DR3 英文名称： 死亡受体3抗体 0.1ml

极光激酶B抗体 Anti-Aurora B 0.1ml

ZSWIM3 英文名称： ZSWIM3蛋白抗体 0.2ml

DERP6 英文名称： 表皮源性蛋白6抗体 0.2ml

载脂蛋白H抗体 Anti-ApoH 0.1ml

Anti-AFP/FITC 荧光标记鼠抗人甲胎蛋白单克隆抗体IgGMulti-class antibodies规格： 0.2ml

Rhesus antibody Rh phospho-EPH A3+A4+A5 ( Tyr779) 磷酸化内皮细胞受体蛋白酪氨酸激酶A3+A4+A5抗体 规格 0.1ml

DP-I/DSP(desmoplakin I ) 桥粒斑蛋白1抗原Multi-class antibodies规格： 0.5mg

Sodiumlaurylsulfateagar

Dichloran Rose-Bengal Chloramphenicol Agar Dichloran 1.00466.0500 MERCK默克 incubation media Dichloran Rose-Bengal Chloramphenicol Agar Dichloran 1.00466.0500 MERCK默克

GVC增菌液 250g 用于椰毒假单胞菌酵米面亚种的增菌培养基

C57BL/6小鼠脂肪间质干细胞成脂诱导分化培养基C57BL/6mouseadiposemesenchymalstemcellsintotheculturemediuminduceddifferentiationoffat

TrypticaseSoy-YeastExtractBroth

LM-250g用于滤膜法单增李氏菌选择性分离(NEOGEN标准)

马尿酸培养基 Ma niu sodium medium 用于弯曲杆菌的马尿酸水解试验(GB标准)

SS琼脂 Salmonella Shigella Agar 250克 沙门氏菌属和志贺氏菌属的分离培养

HTM培养基250g/瓶用于副嗜血杆菌纸片扩散法药敏试验，每升培养基中需添加无菌NADincubationmediaHTM培养基250g/瓶用于副嗜血杆菌纸片扩散法药敏试验，每升培养基中需添加无菌NAD

biochemicalidentifi

磷酸化细胞核因子/k基因结合核因子p100抗体规格 庖肉培养基基础  规格：  250g  用途：  用于厌氧菌的增菌培养和保存，还用于肉毒梭菌及兼性厌氧和厌氧梭状芽孢杆菌的检验(GB/T 8538-200...

动力—盐培养基(A法)  规格：  250g  用途：  用于鉴别细菌动力和盐还原试验(GB/T 8538-2008，GB/T4789.28－2003中4.72 ，GB/T4789.14－20...

纳氏试剂  规格：  10ml/瓶  用途：  用于绿脓杆菌分解乙酰胺产试验。

氧化酶试纸  规格：  10片/盒  用途：  用于氧化酶试验。